ATE100331T1 - Verfahren zur behandlung von septischem schock. - Google Patents
Verfahren zur behandlung von septischem schock.Info
- Publication number
- ATE100331T1 ATE100331T1 AT91902317T AT91902317T ATE100331T1 AT E100331 T1 ATE100331 T1 AT E100331T1 AT 91902317 T AT91902317 T AT 91902317T AT 91902317 T AT91902317 T AT 91902317T AT E100331 T1 ATE100331 T1 AT E100331T1
- Authority
- AT
- Austria
- Prior art keywords
- septic shock
- treatment
- methods
- antagonist
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/248—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fertilizers (AREA)
- Treatment Of Sludge (AREA)
- Compression-Type Refrigeration Machines With Reversible Cycles (AREA)
- Spinning Or Twisting Of Yarns (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44519289A | 1989-12-04 | 1989-12-04 | |
| PCT/US1990/006872 WO1991007986A1 (en) | 1989-12-04 | 1990-11-30 | Method of treating septic shock |
| EP91902317A EP0504307B1 (de) | 1989-12-04 | 1991-06-28 | Verfahren zur behandlung von septischem schock |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE100331T1 true ATE100331T1 (de) | 1994-02-15 |
Family
ID=23767939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91902317T ATE100331T1 (de) | 1989-12-04 | 1991-06-28 | Verfahren zur behandlung von septischem schock. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0504307B1 (de) |
| JP (1) | JPH0747547B2 (de) |
| AT (1) | ATE100331T1 (de) |
| AU (1) | AU648777B2 (de) |
| CA (1) | CA2070424A1 (de) |
| DE (1) | DE69006221T2 (de) |
| DK (1) | DK0504307T3 (de) |
| ES (1) | ES2062762T3 (de) |
| FI (1) | FI922551A0 (de) |
| HU (1) | HUT64481A (de) |
| WO (1) | WO1991007986A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0672144A1 (de) * | 1992-10-20 | 1995-09-20 | Chiron Corporation | Interleukin-6-receptor-antagonisten |
| JP3525221B2 (ja) * | 1993-02-17 | 2004-05-10 | 味の素株式会社 | 免疫抑制剤 |
| CA2163032C (en) * | 1993-06-03 | 2001-02-06 | John Landon | Antibody fragments in therapy |
| DE4409513C1 (de) * | 1994-02-07 | 1995-10-19 | Knoll Ag | Verwendung von anti-TNF-Antikörpern als Arzneimittel zur Behandlung von Erkrankungen mit einem erhöhten Interleukin-6 Serumspiegel |
| US8017121B2 (en) | 1994-06-30 | 2011-09-13 | Chugai Seiyaku Kabushika Kaisha | Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| CA2201781C (en) * | 1994-10-07 | 2010-01-12 | Tadamitsu Kishimoto | Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component |
| AU730308B2 (en) * | 1997-06-18 | 2001-03-01 | Rockefeller University, The | Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
| ES2564635T3 (es) | 2008-05-13 | 2016-03-28 | Novimmune Sa | Anticuerpos anti-IL-6/IL-6R y métodos de uso de los mismos |
| US8188235B2 (en) | 2008-06-18 | 2012-05-29 | Pfizer Inc. | Antibodies to IL-6 and their uses |
| TW202444922A (zh) | 2023-03-31 | 2024-11-16 | 國立大學法人大阪大學 | 用於預測敗血症患者之預後的生物標記及其用途 |
| CN119667163B (zh) * | 2024-10-18 | 2025-12-09 | 中国科学技术大学 | Il-1r2在鉴定对象免疫状态中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2598666B2 (ja) * | 1987-10-19 | 1997-04-09 | 忠三 岸本 | 抗ヒトbcdfモノクローナル抗体 |
| CA1341588C (en) * | 1988-01-26 | 2009-01-06 | Michel Revel | Human ifn-beta2/i1-6, its purification and use |
| KR900700132A (ko) * | 1988-02-02 | 1990-08-11 | 에릭 에스. 딕커 | 면역 글로불린 e 반응 억제 방법 |
| EP0399429A1 (de) * | 1989-05-22 | 1990-11-28 | Toray Industries, Inc. | Monoklonaler Antikörper gegen menschliches Interleukin-6 |
-
1990
- 1990-11-30 HU HU9201859A patent/HUT64481A/hu unknown
- 1990-11-30 FI FI922551A patent/FI922551A0/fi not_active Application Discontinuation
- 1990-11-30 ES ES91902317T patent/ES2062762T3/es not_active Expired - Lifetime
- 1990-11-30 WO PCT/US1990/006872 patent/WO1991007986A1/en not_active Ceased
- 1990-11-30 JP JP3502346A patent/JPH0747547B2/ja not_active Expired - Lifetime
- 1990-11-30 DK DK91902317.6T patent/DK0504307T3/da active
- 1990-11-30 DE DE91902317T patent/DE69006221T2/de not_active Expired - Fee Related
- 1990-11-30 CA CA002070424A patent/CA2070424A1/en not_active Abandoned
- 1990-11-30 AU AU71794/91A patent/AU648777B2/en not_active Ceased
-
1991
- 1991-06-28 AT AT91902317T patent/ATE100331T1/de not_active IP Right Cessation
- 1991-06-28 EP EP91902317A patent/EP0504307B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1991007986A8 (en) | 2004-04-22 |
| JPH0747547B2 (ja) | 1995-05-24 |
| HUT64481A (en) | 1994-01-28 |
| HU9201859D0 (en) | 1992-09-28 |
| DE69006221T2 (de) | 1994-05-05 |
| AU648777B2 (en) | 1994-05-05 |
| CA2070424A1 (en) | 1991-06-05 |
| FI922551A7 (fi) | 1992-06-03 |
| EP0504307A1 (de) | 1992-09-23 |
| WO1991007986A1 (en) | 1991-06-13 |
| FI922551L (fi) | 1992-06-03 |
| ES2062762T3 (es) | 1994-12-16 |
| AU7179491A (en) | 1991-06-26 |
| FI922551A0 (fi) | 1992-06-03 |
| DE69006221D1 (de) | 1994-03-03 |
| JPH05504058A (ja) | 1993-07-01 |
| DK0504307T3 (da) | 1994-03-21 |
| EP0504307B1 (de) | 1994-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA111707C2 (uk) | Застосування виділеного анти-tnf-альфа антитіла людини | |
| DE69010893D1 (de) | Verfahren zur behandlung von koks sowie löschen desselben. | |
| DE3583796D1 (de) | Verfahren zur behandlung von materialien mittels organosiloxanverbindungen. | |
| DE69228556D1 (de) | CDw52-SPEZIFISCHER ANTIKÖRPER ZUR BEHANDLUNG VON MULTIPLER SKLEROSE | |
| DE3674308D1 (de) | Biozide zusammensetzungund verfahren zur behandlung von wasser. | |
| DE3877834D1 (de) | Verfahren zur behandlung von abgasen. | |
| DE69008820D1 (de) | Verfahren zur Behandlung von Polymerisaten. | |
| ATE100331T1 (de) | Verfahren zur behandlung von septischem schock. | |
| ATE166230T1 (de) | Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock | |
| ATA237789A (de) | Verfahren zur behandlung von nassem nadel- oder laubbaumholz | |
| AT378945B (de) | Verfahren zur behandlung von soleabschlaemmungen | |
| ATE484294T1 (de) | Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen | |
| DE69615843D1 (de) | Il-8 antagonisten zur behandlung von asthma | |
| DE59102745D1 (de) | Verfahren une einrichtung zur behandlung von saatgut. | |
| AT356025B (de) | Verfahren zur behandlung von abwasser oder fermentationsbruehen | |
| DE69607559D1 (de) | Verfahren zur Behandlung von Phenolteer | |
| DE3670145D1 (de) | Verfahren zur behandlung von abfall. | |
| DE60015791D1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| DE68911653D1 (de) | Antagonist für Interleukin-5 zur Verhütung oder Verminderung von Eosinophilie. | |
| DE58902128D1 (de) | Verfahren zur behandlung von klaerschlamm. | |
| ATE251462T1 (de) | Verfahren zur behandlung von narbengewebe | |
| DE69006509D1 (de) | Verfahren zur behandlung von häuten. | |
| EA199800535A1 (ru) | Способ лечения боли | |
| ATA412581A (de) | Verfahren zur behandlung von abwasser | |
| DE68913995D1 (de) | Zusammensetzung zur behandlung progressiver myopie. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |